• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用调查评估针对乌干达霍伊马地区霍乱疫情的综合口服霍乱疫苗运动。

Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda.

机构信息

Department of Community Health, Ministry of Health, Kampala, Uganda.

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

出版信息

BMJ Open. 2020 Dec 10;10(12):e038464. doi: 10.1136/bmjopen-2020-038464.

DOI:10.1136/bmjopen-2020-038464
PMID:33303438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7733212/
Abstract

OBJECTIVES

To evaluate the quality and coverage of the campaign to distribute oral cholera vaccine (OCV) during a cholera outbreak in Hoima, Uganda to guide future campaigns of cholera vaccine.

DESIGN

Survey of communities targeted for vaccination to determine vaccine coverage rates and perceptions of the vaccination campaign, and a separate survey of vaccine staff who carried out the campaign.

SETTING

Hoima district, Uganda.

PARTICIPANTS

Representative clusters of households residing in the communities targeted for vaccination and staff members who conducted the vaccine campaign.

RESULTS

Among 209 households (1274 individuals) included in the coverage survey, 1193 (94%; 95% CI 92% to 95%) reported receiving at least one OCV dose and 998 (78%; 95% CI 76% to 81%) reported receiving two doses. Among vaccinated individuals, minor complaints were reported by 71 persons (5.6%). Individuals with 'some' education (primary school or above) were more knowledgeable regarding the required OCV doses compared with non-educated (p=0.03). Factors negatively associated with campaign implementation included community sensitisation time, staff payment and problems with field transport. Although the campaign was carried out quickly, the outbreak was over before the campaign started. Most staff involved in the campaign (93%) were knowledgeable about cholera control; however, 29% did not clearly understand how to detect and manage adverse events following immunisation.

CONCLUSION

The campaign achieved high OCV coverage, but the surveys provided insights for improvement. To achieve high vaccine coverage, more effort is needed for community sensitisation, and additional resources for staff transportation and timely payment for campaign staff is required. Pretest and post-test assessment of staff training can identify and address knowledge and skill gaps.

摘要

目的

评估乌干达霍伊马暴发霍乱期间分发口服霍乱疫苗(OCV)运动的质量和覆盖范围,为今后的霍乱疫苗运动提供指导。

设计

对目标接种社区进行调查,以确定疫苗接种率和对疫苗接种运动的看法,并对开展疫苗接种运动的疫苗工作人员进行单独调查。

地点

乌干达霍伊马区。

参与者

目标接种社区的代表性住户群和开展疫苗接种运动的工作人员。

结果

在接受覆盖率调查的 209 户家庭(1274 人)中,有 1193 人(94%;95%CI 92%至 95%)报告至少接种了一剂 OCV,998 人(78%;95%CI 76%至 81%)报告接种了两剂。在接种疫苗的人群中,有 71 人(5.6%)报告出现轻微不适。与未受教育者相比(p=0.03),具有“一定”教育程度(小学及以上)的个体对所需的 OCV 剂量了解更多。与运动实施相关的负面因素包括社区宣传时间、工作人员薪酬和实地交通问题。尽管该运动迅速开展,但疫情在运动开始前就已结束。参与运动的大多数工作人员(93%)都了解霍乱控制;然而,29%的工作人员不清楚如何发现和管理疫苗接种后不良反应。

结论

该运动实现了较高的 OCV 接种率,但调查结果为改进提供了思路。为了实现高疫苗接种率,需要加大社区宣传力度,为工作人员交通和及时支付运动工作人员薪酬提供额外资源。对工作人员培训进行预测试和后测试评估,可以确定并解决知识和技能差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58a7/7733212/c230cc6f1921/bmjopen-2020-038464f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58a7/7733212/12f8cb86c2f6/bmjopen-2020-038464f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58a7/7733212/c230cc6f1921/bmjopen-2020-038464f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58a7/7733212/12f8cb86c2f6/bmjopen-2020-038464f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58a7/7733212/c230cc6f1921/bmjopen-2020-038464f02.jpg

相似文献

1
Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda.利用调查评估针对乌干达霍伊马地区霍乱疫情的综合口服霍乱疫苗运动。
BMJ Open. 2020 Dec 10;10(12):e038464. doi: 10.1136/bmjopen-2020-038464.
2
Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool.在莫桑比克尼亚萨省库安巴地区开展的预防性口服霍乱疫苗(OCV)大规模疫苗接种运动:使用 CholTool 的可行性、疫苗接种覆盖率和交付成本。
BMJ Open. 2022 Sep 7;12(9):e053585. doi: 10.1136/bmjopen-2021-053585.
3
Euvichol-plus vaccine campaign coverage during the 2017/2018 cholera outbreak in Lusaka district, Zambia: a cross-sectional descriptive study.赞比亚卢萨卡地区 2017/2018 年霍乱疫情期间欧维奇奥普斯疫苗接种运动的覆盖情况:一项横断面描述性研究。
BMJ Open. 2023 Oct 5;13(10):e070796. doi: 10.1136/bmjopen-2022-070796.
4
Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.在马拉维应对霍乱疫情和洪水时开展口服霍乱疫苗大规模接种运动的可行性和可接受性。
Pan Afr Med J. 2016 Apr 20;23:203. doi: 10.11604/pamj.2016.23.203.8346. eCollection 2016.
5
High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.海地应急运动后霍乱疫苗高接种率:2017 年在南部三省三个农村公社进行的群组调查结果。
PLoS Negl Trop Dis. 2020 Jan 31;14(1):e0007967. doi: 10.1371/journal.pntd.0007967. eCollection 2020 Jan.
6
Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.口服霍乱疫苗在莫桑比克楠普拉省预防性挨家挨户大规模疫苗接种运动中的覆盖情况。
PLoS One. 2018 Oct 3;13(10):e0198592. doi: 10.1371/journal.pone.0198592. eCollection 2018.
7
Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.延迟至高危霍乱传播期前接种第二剂口服霍乱疫苗:2016 年卢萨卡霍乱控制策略。
PLoS One. 2019 Aug 30;14(8):e0219040. doi: 10.1371/journal.pone.0219040. eCollection 2019.
8
Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.2017 年索马里急性紧急情况下的口服霍乱疫苗接种覆盖率。
Vaccine. 2020 Feb 29;38 Suppl 1:A141-A147. doi: 10.1016/j.vaccine.2020.01.015. Epub 2020 Jan 21.
9
Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey.乌干达多个热点地区的霍乱和 COVID-19 大流行预防:疫苗接种覆盖率、疫苗接种后不良反应和 WASH 条件调查。
BMC Infect Dis. 2023 Jul 21;23(1):487. doi: 10.1186/s12879-023-08462-y.
10
A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.喀麦隆霍乱疫情期间开展的单次口服霍乱疫苗(OCV)反应性接种运动。
Vaccine. 2021 Feb 22;39(8):1290-1296. doi: 10.1016/j.vaccine.2021.01.017. Epub 2021 Jan 23.

引用本文的文献

1
Assessment of Management Factors Influencing Vaccination Against Cholera in the Health District of Katana, the Democratic Republic of the Congo.刚果民主共和国卡塔纳卫生区影响霍乱疫苗接种的管理因素评估
Health Serv Insights. 2025 Feb 7;18:11786329251316675. doi: 10.1177/11786329251316675. eCollection 2025.
2
Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon.黎巴嫩口服霍乱疫苗免疫接种后不良事件的描述性分析。
Front Public Health. 2024 Nov 20;12:1480744. doi: 10.3389/fpubh.2024.1480744. eCollection 2024.
3
Rapid cholera outbreak control following catastrophic landslides and floods: A case study of Bududa district, Uganda.

本文引用的文献

1
Oral cholera vaccination in hard-to-reach communities, Lake Chilwa, Malawi.马拉维奇利瓦湖偏远社区的口服霍乱疫苗接种。
Bull World Health Organ. 2018 Dec 1;96(12):817-825. doi: 10.2471/BLT.17.206417. Epub 2018 Sep 27.
2
The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.Euvichol 的故事——通过全球公私合作伙伴关系开发和许可安全、有效且负担得起的口服霍乱疫苗。
Vaccine. 2018 Oct 29;36(45):6606-6614. doi: 10.1016/j.vaccine.2018.09.026. Epub 2018 Oct 9.
3
Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
灾难后迅速控制霍乱暴发:以乌干达布杜达区为例的案例研究。
Afr Health Sci. 2023 Dec;23(4):203-215. doi: 10.4314/ahs.v23i4.23.
4
Euvichol-plus vaccine campaign coverage during the 2017/2018 cholera outbreak in Lusaka district, Zambia: a cross-sectional descriptive study.赞比亚卢萨卡地区 2017/2018 年霍乱疫情期间欧维奇奥普斯疫苗接种运动的覆盖情况:一项横断面描述性研究。
BMJ Open. 2023 Oct 5;13(10):e070796. doi: 10.1136/bmjopen-2022-070796.
5
Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey.乌干达多个热点地区的霍乱和 COVID-19 大流行预防:疫苗接种覆盖率、疫苗接种后不良反应和 WASH 条件调查。
BMC Infect Dis. 2023 Jul 21;23(1):487. doi: 10.1186/s12879-023-08462-y.
6
A scoping review of facilitators and barriers influencing the implementation of surveillance and oral cholera vaccine interventions for cholera control in lower- and middle-income countries.一项关于影响中低收入国家霍乱控制中监测和口服霍乱疫苗干预措施实施的促进因素和障碍的范围综述。
BMC Public Health. 2023 Mar 8;23(1):455. doi: 10.1186/s12889-023-15326-2.
7
Strengthening vaccination delivery system resilience in the context of protracted humanitarian crisis: a realist-informed systematic review.在持久人道主义危机背景下加强疫苗接种提供系统的弹性:基于现实主义理论的系统评价。
BMC Health Serv Res. 2022 Oct 23;22(1):1277. doi: 10.1186/s12913-022-08653-4.
8
Controlled Human Infection Models To Accelerate Vaccine Development.控制人体感染模型以加速疫苗开发。
Clin Microbiol Rev. 2022 Sep 21;35(3):e0000821. doi: 10.1128/cmr.00008-21. Epub 2022 Jul 6.
9
Contrasting Epidemiology of Cholera in Bangladesh and Africa.孟加拉国和非洲霍乱的流行病学对比。
J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S701-S709. doi: 10.1093/infdis/jiab440.
10
Cholera Hot-Spots and Contextual Factors in Burundi, Planning for Elimination.布隆迪霍乱热点地区及背景因素,消除霍乱的规划
Trop Med Infect Dis. 2021 May 11;6(2):76. doi: 10.3390/tropicalmed6020076.
口服霍乱疫苗在莫桑比克楠普拉省预防性挨家挨户大规模疫苗接种运动中的覆盖情况。
PLoS One. 2018 Oct 3;13(10):e0198592. doi: 10.1371/journal.pone.0198592. eCollection 2018.
4
Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.孟加拉国 Keraniganj 农村地区,利用现有的国家免疫服务提供机制,由 icddr,b 开展口服霍乱疫苗接种的可行性、覆盖范围和成本。
Hum Vaccin Immunother. 2019;15(6):1302-1309. doi: 10.1080/21645515.2018.1528833. Epub 2018 Nov 28.
5
Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030.全球霍乱流行病学:到 2030 年减少霍乱负担的机会。
J Infect Dis. 2018 Oct 15;218(suppl_3):S137-S140. doi: 10.1093/infdis/jiy486.
6
No end to cholera without basic water, sanitation and hygiene.没有基本的水、环境卫生和个人卫生,霍乱就不会终结。
Bull World Health Organ. 2018 Jun 1;96(6):371-371A. doi: 10.2471/BLT.18.213678.
7
Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.在城市环境中开展高针对性的霍乱疫苗接种活动是可行的:刚果民主共和国卡莱米的经验。
PLoS Negl Trop Dis. 2018 May 7;12(5):e0006369. doi: 10.1371/journal.pntd.0006369. eCollection 2018 May.
8
Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.绘制撒哈拉以南非洲地区霍乱负担图及其对控制的影响:跨地理尺度数据分析。
Lancet. 2018 May 12;391(10133):1908-1915. doi: 10.1016/S0140-6736(17)33050-7. Epub 2018 Mar 1.
9
Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.实施研究:用一剂口服霍乱疫苗进行反应性大规模疫苗接种,赞比亚。
Bull World Health Organ. 2018 Feb 1;96(2):86-93. doi: 10.2471/BLT.16.189241. Epub 2017 Oct 19.
10
Identifying cholera "hotspots" in Uganda: An analysis of cholera surveillance data from 2011 to 2016.识别乌干达的霍乱“热点地区”:对2011年至2016年霍乱监测数据的分析
PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006118. doi: 10.1371/journal.pntd.0006118. eCollection 2017 Dec.